Yufang Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yufang Gao has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Yuxiu Liu
Post-Doctoral Station of Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
5 shared publicationsQi Li
School of Nursing, Qingdao University
4 shared publications- Jianxun Wang
School of Basic Medicine, Qingdao University, Qingdao, China
3 shared publications Zhe Su
Department of Emergency Internal Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
3 shared publicationsZhongjie Yu
Institute for Translational Medicine, Qingdao University, Qingdao, China
3 shared publicationsLei Song
Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China
2 shared publications
Latest Publications
- 21 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 2) , 113394
Urolithin A improves myocardial ischemia–reperfusion injury by attenuating oxidative stress and ferroptosis through Nrf2 pathway
- 21 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 2) , 113394
Urolithin A improves myocardial ischemia–reperfusion injury by attenuating oxidative stress and ferroptosis through Nrf2 pathway
- 27 December 2023
- Published by Wiley in The FEBS Journal
- Vol. 291 (6) , 1246-1263
Circular RNA‐circLRP6 protects cardiomyocyte from hypoxia‐induced apoptosis by facilitating hnRNPM‐mediated expression of FGF‐9
Coronary atherosclerosis‐induced myocardial ischemia leads to cardiomyocyte apoptosis. The regulatory mechanisms for cardiomyocyte apoptosis have not been fully understood. Circular RNAs are non‐coding RNAs which play important roles in heart function maintenance and progression of heart diseases by regulating gene transcription and protein translation. Here, we reported a conserved cardiac circular RNA, which is generated from the second exon of LRP6 and named circLRP62‐2. CircLRP62‐2 can protect cardiomyocyte from hypoxia‐induced apoptosis. The expression of circLRP62‐2 in cardiomyocytes was down‐regulated under hypoxia, while forced expression of circLRP62‐2 inhibited cell apoptosis. Normally, circLRP62‐2 was mainly localized in the nucleus. Under hypoxia, circLRP62‐2 is associated with heterogeneous nuclear ribonucleoprotein M (hnRNPM) to be translocated into the cytoplasm. It recruited hnRNPM to fibroblast growth factor 9 (FGF9) mRNA to enhance the expression of FGF9 protein, promoting hypoxia‐adaption and viability of cardiomyocytes. In summary, this study uncovers a new inhibitor of apoptosis and reveals a novel anti‐apoptotic pathway composed of circLRP62‐2, hnRNPM, and FGF9, which may provide therapeutic targets for coronary heart disease and ischemic myocardial injury.
- 27 December 2023
- Published by Wiley in The FEBS Journal
- Vol. 291 (6) , 1246-1263
Circular RNA‐circLRP6 protects cardiomyocyte from hypoxia‐induced apoptosis by facilitating hnRNPM‐mediated expression of FGF‐9
Coronary atherosclerosis‐induced myocardial ischemia leads to cardiomyocyte apoptosis. The regulatory mechanisms for cardiomyocyte apoptosis have not been fully understood. Circular RNAs are non‐coding RNAs which play important roles in heart function maintenance and progression of heart diseases by regulating gene transcription and protein translation. Here, we reported a conserved cardiac circular RNA, which is generated from the second exon of LRP6 and named circLRP62‐2. CircLRP62‐2 can protect cardiomyocyte from hypoxia‐induced apoptosis. The expression of circLRP62‐2 in cardiomyocytes was down‐regulated under hypoxia, while forced expression of circLRP62‐2 inhibited cell apoptosis. Normally, circLRP62‐2 was mainly localized in the nucleus. Under hypoxia, circLRP62‐2 is associated with heterogeneous nuclear ribonucleoprotein M (hnRNPM) to be translocated into the cytoplasm. It recruited hnRNPM to fibroblast growth factor 9 (FGF9) mRNA to enhance the expression of FGF9 protein, promoting hypoxia‐adaption and viability of cardiomyocytes. In summary, this study uncovers a new inhibitor of apoptosis and reveals a novel anti‐apoptotic pathway composed of circLRP62‐2, hnRNPM, and FGF9, which may provide therapeutic targets for coronary heart disease and ischemic myocardial injury.
- Open Access
- 6 June 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 810257
The Particular Expression Profiles of Circular RNA in Peripheral Blood of Myocardial Infarction Patients by RNA Sequencing
Myocardial infarction (MI) is one of the most common illnesses seriously harmful to human health. Notwithstanding, the systems of its pathogenesis are as yet not totally demonstrated. CircRNA is one sort of non-coding RNA, and late distributed information proposes that circRNAs assume a significant part in heart diseases; however, their expression profiles in the peripheral blood of patients with MI are not yet totally characterized. Therefore, RNAs from peripheral blood were recruited for high-throughput RNA-seq analysis. A total of 3,862 circRNAs were distinguished to be remarkably different, including 2,738 circRNAs being upregulated and 1,124 circRNAs being downregulated. circTMEM165, circUBAC2, circZNF609, circANKRD12, and circSLC8A1 were reconfirmed by RT-qPCR in the cell model. ROC curves uncovered that they have great sensitivity and specificity in the determination of MI. Besides, circRNAs are associated with cell metabolism and function by directing complex networks among circular RNAs, microRNAs, and messenger RNAs. In outline, our study portrayed the specific articulation profiles of circular RNA in patients with MI. The outcomes showed that circRNAs might fill in as a sort of ideal biomarkers for MI diagnosis. Further exploration of these circRNAs may enrich our understanding of MI etiology and progression.
- 6 June 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 810257
Open AccessThe Particular Expression Profiles of Circular RNA in Peripheral Blood of Myocardial Infarction Patients by RNA Sequencing
Myocardial infarction (MI) is one of the most common illnesses seriously harmful to human health. Notwithstanding, the systems of its pathogenesis are as yet not totally demonstrated. CircRNA is one sort of non-coding RNA, and late distributed information proposes that circRNAs assume a significant part in heart diseases; however, their expression profiles in the peripheral blood of patients with MI are not yet totally characterized. Therefore, RNAs from peripheral blood were recruited for high-throughput RNA-seq analysis. A total of 3,862 circRNAs were distinguished to be remarkably different, including 2,738 circRNAs being upregulated and 1,124 circRNAs being downregulated. circTMEM165, circUBAC2, circZNF609, circANKRD12, and circSLC8A1 were reconfirmed by RT-qPCR in the cell model. ROC curves uncovered that they have great sensitivity and specificity in the determination of MI. Besides, circRNAs are associated with cell metabolism and function by directing complex networks among circular RNAs, microRNAs, and messenger RNAs. In outline, our study portrayed the specific articulation profiles of circular RNA in patients with MI. The outcomes showed that circRNAs might fill in as a sort of ideal biomarkers for MI diagnosis. Further exploration of these circRNAs may enrich our understanding of MI etiology and progression.
- Open Access
- 1 September 2021
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 15, 1981-1990
Demands for Telenursing-Based Long-Term Care Among Disabled Older Adults in Qingdao, China: A Cross-Sectional Study
Purpose: The purpose of the present study was to investigate the current status of and factors influencing the demands for telenursing-based long-term care in disabled older adults. Methods: In this cross-sectional study, data from 213 participants from five districts of Qingdao, China, were investigated using multistage stratified sampling. The assessment scale of the long-term care demands level and the questionnaire of the demands of telenursing-based long-term care for disabled older adults were used to estimate the demands for telenursing-based long-term care for older adults with disabilities in Qingdao. Results: Of the participants, 60.51% were willing to receive telenursing-based long-term care. The item with the highest score was “Internet +” information management and first aid (3.77 ± 0.71); the item with the lowest score was “Internet +” daily care (2.97 ± 0.72). Average family income (P < 0.001), age (P = 0.004) and educational level (P = 0.003) were significant factors influencing the demands for telenursing-based long-term care. Conclusion: Disabled older adults had a high demand for telenursing-based long-term care. Urgent actions are needed to integrate telenursing with long-term care as soon as possible. In the development of telenursing-based long-term care, it is necessary to fully consider the average family income, age and educational level of disabled older adults.
- 1 September 2021
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 15, 1981-1990
Open AccessDemands for Telenursing-Based Long-Term Care Among Disabled Older Adults in Qingdao, China: A Cross-Sectional Study
Purpose: The purpose of the present study was to investigate the current status of and factors influencing the demands for telenursing-based long-term care in disabled older adults. Methods: In this cross-sectional study, data from 213 participants from five districts of Qingdao, China, were investigated using multistage stratified sampling. The assessment scale of the long-term care demands level and the questionnaire of the demands of telenursing-based long-term care for disabled older adults were used to estimate the demands for telenursing-based long-term care for older adults with disabilities in Qingdao. Results: Of the participants, 60.51% were willing to receive telenursing-based long-term care. The item with the highest score was “Internet +” information management and first aid (3.77 ± 0.71); the item with the lowest score was “Internet +” daily care (2.97 ± 0.72). Average family income (P < 0.001), age (P = 0.004) and educational level (P = 0.003) were significant factors influencing the demands for telenursing-based long-term care. Conclusion: Disabled older adults had a high demand for telenursing-based long-term care. Urgent actions are needed to integrate telenursing with long-term care as soon as possible. In the development of telenursing-based long-term care, it is necessary to fully consider the average family income, age and educational level of disabled older adults.
- 4 July 2020
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 22 (6) , 987-991
Peripherally inserted central catheter malposition to a persistent left superior vena cava: A successful case to leave the catheter till the end of chemotherapy
Persistent left superior vena cava is rare and asymptomatic and is usually discovered incidentally during or after insertion of a central venous catheter. There is uncertainty as to whether or not the catheter should be removed after its malposition resulting in persistent left superior vena cava. We reported an unusual case of a breast cancer patient with a persistent left superior vena cava detected after a peripherally inserted central catheter insertion. The patient had undergone a modified radical mastectomy and needed to insert a peripherally inserted central catheter for chemotherapy. After the peripherally inserted central catheter insertion, the chest X-ray and computed tomography showed that the catheter was located in the persistent left superior vena cava. After an assessment of the persistent left superior vena cava and the catheter tip position, the peripherally inserted central catheter remained in the persistent left superior vena cava for further therapy. To ensure the integrity of the catheter, special follow-ups and tip position observations were carried out. The peripherally inserted central catheter was safe until the end of chemotherapy with no complications. Although the peripherally inserted central catheter tip was located in persistent left superior vena cava, given that the persistent left superior vena cava coexisted with a right superior vena cava with the similar lumen, the peripherally inserted central catheter could be used normally under strict attention.
- 4 July 2020
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 22 (6) , 987-991
Peripherally inserted central catheter malposition to a persistent left superior vena cava: A successful case to leave the catheter till the end of chemotherapy
Persistent left superior vena cava is rare and asymptomatic and is usually discovered incidentally during or after insertion of a central venous catheter. There is uncertainty as to whether or not the catheter should be removed after its malposition resulting in persistent left superior vena cava. We reported an unusual case of a breast cancer patient with a persistent left superior vena cava detected after a peripherally inserted central catheter insertion. The patient had undergone a modified radical mastectomy and needed to insert a peripherally inserted central catheter for chemotherapy. After the peripherally inserted central catheter insertion, the chest X-ray and computed tomography showed that the catheter was located in the persistent left superior vena cava. After an assessment of the persistent left superior vena cava and the catheter tip position, the peripherally inserted central catheter remained in the persistent left superior vena cava for further therapy. To ensure the integrity of the catheter, special follow-ups and tip position observations were carried out. The peripherally inserted central catheter was safe until the end of chemotherapy with no complications. Although the peripherally inserted central catheter tip was located in persistent left superior vena cava, given that the persistent left superior vena cava coexisted with a right superior vena cava with the similar lumen, the peripherally inserted central catheter could be used normally under strict attention.
- Open Access
- 9 June 2020
- Published by Springer Nature in Research Square
The Expression Profiles and Role of Circular RNA in Peripheral Blood of Myocardial Infarction Patients
Background: Myocardial infarction (MI) is one of the most widespread illnesses seriously harmful to human health. However, the mechanisms of its pathogenesis have not yet been completely proved. circRNA is one kind of non-coding RNA, recently published data suggests that circRNAs play a crucial role in heart diseases, but their expression profiles and role in MI patients are not yet completely defined. Methods: RNAs from peripheral blood samples were recruited for high-throughput RNA-seq analysis; The junction site part of circRNAs was confirmed by PCR with divergent primers; ROC curves were created to estimate the diagnostic value of circRNAs for MI; The expression level of circRNAs in clinical and cell samples were detected by RT-qPCR; MiRNA target site in exons of circRNA loci was verified by using miRanda, The binding sites of miRNA and mRNA were predicted by RNAhybrid; The regulatory roles of circSLC8A1 in cardiomyocytes were detected by TUNEL and Immunoblotting.Results: A total of 3862 circRNAs were detected to be remarkably changed, including 2738 circRNAs being upregulated, 1124 circRNAs being downregulated. circTMEM165, circUBAC2, circZNF609, circANKRD12, and circSLC8A1 were upregulated in MI and had closed loop structure. The results of ROC curves revealed that these five circRNAs had good sensitivity and specificity for MI diagnosis. Moreover, we created networks among circRNAs, miRNAs and mRNAs to predict the regulatory roles of circRNAs in MI. Besides that, we also demonstrated that circSLC8A1 contributed to cardiomyocytes apoptosis. Conclusions: In this study, we depicted the expression profiles of circular RNA in peripheral blood of myocardial infarction patients, revealed the five circRNAs may be very beneficial for MI diagnosis and regarded as possible biomarkers. Moreover, we also revealed that circSLC8A1 played a critical role in cardiomyocytes apoptosis.
- 9 June 2020
- Published by Springer Nature in Research Square
Open AccessThe Expression Profiles and Role of Circular RNA in Peripheral Blood of Myocardial Infarction Patients
Background: Myocardial infarction (MI) is one of the most widespread illnesses seriously harmful to human health. However, the mechanisms of its pathogenesis have not yet been completely proved. circRNA is one kind of non-coding RNA, recently published data suggests that circRNAs play a crucial role in heart diseases, but their expression profiles and role in MI patients are not yet completely defined. Methods: RNAs from peripheral blood samples were recruited for high-throughput RNA-seq analysis; The junction site part of circRNAs was confirmed by PCR with divergent primers; ROC curves were created to estimate the diagnostic value of circRNAs for MI; The expression level of circRNAs in clinical and cell samples were detected by RT-qPCR; MiRNA target site in exons of circRNA loci was verified by using miRanda, The binding sites of miRNA and mRNA were predicted by RNAhybrid; The regulatory roles of circSLC8A1 in cardiomyocytes were detected by TUNEL and Immunoblotting.Results: A total of 3862 circRNAs were detected to be remarkably changed, including 2738 circRNAs being upregulated, 1124 circRNAs being downregulated. circTMEM165, circUBAC2, circZNF609, circANKRD12, and circSLC8A1 were upregulated in MI and had closed loop structure. The results of ROC curves revealed that these five circRNAs had good sensitivity and specificity for MI diagnosis. Moreover, we created networks among circRNAs, miRNAs and mRNAs to predict the regulatory roles of circRNAs in MI. Besides that, we also demonstrated that circSLC8A1 contributed to cardiomyocytes apoptosis. Conclusions: In this study, we depicted the expression profiles of circular RNA in peripheral blood of myocardial infarction patients, revealed the five circRNAs may be very beneficial for MI diagnosis and regarded as possible biomarkers. Moreover, we also revealed that circSLC8A1 played a critical role in cardiomyocytes apoptosis.
- Open Access
- 27 December 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (2) , 2040-2051
Baicalein inhibits mitochondrial apoptosis induced by oxidative stress in cardiomyocytes by stabilizing MARCH5 expression
Abnormal mitochondrial fission and mitophagy participate in the pathogenesis of many cardiovascular diseases. Baicalein is a key active component in the roots of traditional Chinese medicinal herb Scutellaria baicalensis Georgi. It has been reported that baicalein can resist cardiotoxicity induced by several stress, but the mechanisms of baicalein operate in the protection of cardiomyocytes need to be researched further. Here we report that baicalein can promote cell survival under oxidative stress by up‐regulating the expression level of MARCH5 in cardiomyocytes. Pre‐treatment cells or mice with baicalein can stabilize the expression of MARCH5, which plays a crucial role in the regulation of mitochondrial network and mitophagy. Overexpressed MARCH5 is able to against H 2 O 2 and ischaemia/reperfusion (I/R) stress by suppressing mitochondrial fission and enhancing mitophagy, and then attenuate cells apoptosis. Altogether, our present study investigated that baicalein exerts a protective effect through regulating KLF4‐MARCH5‐Drp1 pathway, our research also provided a novel theoretical basis for the clinical application of baicalein.
- 27 December 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (2) , 2040-2051
Open AccessBaicalein inhibits mitochondrial apoptosis induced by oxidative stress in cardiomyocytes by stabilizing MARCH5 expression
Abnormal mitochondrial fission and mitophagy participate in the pathogenesis of many cardiovascular diseases. Baicalein is a key active component in the roots of traditional Chinese medicinal herb Scutellaria baicalensis Georgi. It has been reported that baicalein can resist cardiotoxicity induced by several stress, but the mechanisms of baicalein operate in the protection of cardiomyocytes need to be researched further. Here we report that baicalein can promote cell survival under oxidative stress by up‐regulating the expression level of MARCH5 in cardiomyocytes. Pre‐treatment cells or mice with baicalein can stabilize the expression of MARCH5, which plays a crucial role in the regulation of mitochondrial network and mitophagy. Overexpressed MARCH5 is able to against H 2 O 2 and ischaemia/reperfusion (I/R) stress by suppressing mitochondrial fission and enhancing mitophagy, and then attenuate cells apoptosis. Altogether, our present study investigated that baicalein exerts a protective effect through regulating KLF4‐MARCH5‐Drp1 pathway, our research also provided a novel theoretical basis for the clinical application of baicalein.
- 10 October 2019
- Published by Springer Nature in Hypertension Research
- Vol. 43 (1) , 13-22
Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia
Preeclampsia (PE) is a major obstetrical complication that results in maternal and fetal morbidity and mortality. Aberrant epigenetic modifications are widely involved in the pathogenesis of PE. Previously, the activated leukocyte cell adhesion molecule (ALCAM) was reported to be required for blastocyst implantation but has not been described in the context of pathological pregnancy. This study explored the expression of ALCAM and its methylation levels in the placentas and peripheral venous blood of patients with PE from a Chinese Han population. The mRNA and protein expression levels of ALCAM were downregulated in the PE placentas compared with the control placentas (P < 0.05). The methylation rate of the ALCAM gene promoter was considerably elevated in the placentas (P = 0.003, odds ratio (OR) = 0.264, 95% confidence interval (95% CI) [0.108-0.647], cases n = 47, controls n = 53) and peripheral blood (P = 0.007, OR = 0.455, 95% CI [0.256-0.806], cases n = 100, controls n = 100) of the PE patients compared with those of the normotensive women, suggesting a negative relationship between ALCAM methylation and gene transcription. Moreover, the transcriptional expression of ALCAM was dramatically increased by demethylating treatment in trophoblastic cells. ALCAM is expected to be involved in the pathogenesis of PE through methylation regulation.
- 10 October 2019
- Published by Springer Nature in Hypertension Research
- Vol. 43 (1) , 13-22
Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia
Preeclampsia (PE) is a major obstetrical complication that results in maternal and fetal morbidity and mortality. Aberrant epigenetic modifications are widely involved in the pathogenesis of PE. Previously, the activated leukocyte cell adhesion molecule (ALCAM) was reported to be required for blastocyst implantation but has not been described in the context of pathological pregnancy. This study explored the expression of ALCAM and its methylation levels in the placentas and peripheral venous blood of patients with PE from a Chinese Han population. The mRNA and protein expression levels of ALCAM were downregulated in the PE placentas compared with the control placentas (P < 0.05). The methylation rate of the ALCAM gene promoter was considerably elevated in the placentas (P = 0.003, odds ratio (OR) = 0.264, 95% confidence interval (95% CI) [0.108-0.647], cases n = 47, controls n = 53) and peripheral blood (P = 0.007, OR = 0.455, 95% CI [0.256-0.806], cases n = 100, controls n = 100) of the PE patients compared with those of the normotensive women, suggesting a negative relationship between ALCAM methylation and gene transcription. Moreover, the transcriptional expression of ALCAM was dramatically increased by demethylating treatment in trophoblastic cells. ALCAM is expected to be involved in the pathogenesis of PE through methylation regulation.
- Open Access
- 1 July 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 2173-2181
Disclosure of cancer diagnosis in China: the incidence, patients’ situation, and different preferences between patients and their family members and related influence factors
Purpose: The purpose of this study was to investigate the disclosure incidence of cancer diagnosis to patients before chemotherapy, to survey the attitudes of the patients and their families and related influencing factors toward disclosure of cancer diagnosis, and to compare the anxiety and depression levels between the disclosure and non-disclosure patients. Participants and methods: A prospective cohort study was conducted at a tertiary hospital in China. A consecutive series of patients who had been diagnosed with malignancy by pathology and their family member were included in our study from March 2017 to December 2017. Patients’ situation, preferences, and their family members’ preferences were investigated by a self-designed questionnaire following a semi-structured interview. The Chinese version of HADS for anxiety and depression was used to test the patients’ psychological distress. Binary logistic regression was used to analyze the related influencing factors of patients’ disclosure of their diagnosis. Results: A total of 124 pairs of patients and their family members were analyzed. Of the 124 patients, 47 (37.90%) patients knew about their cancer diagnosis and 77 (62.10%) patients did not know about their cancer diagnosis before chemotherapy. There were more patients than family members who wanted the patients to be informed about the diagnosis of terminal illness (91.9% vs 53.2%, PPPP0.05). Conclusion: More than half of the patients did not know their exact diagnosis before chemotherapy in China. Educational level and economic status may be influencing factors for the disclosure of cancer diagnosis. Patients and their family members had different preferences toward diagnosis disclosure.
- 1 July 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 2173-2181
Open AccessDisclosure of cancer diagnosis in China: the incidence, patients’ situation, and different preferences between patients and their family members and related influence factors
Purpose: The purpose of this study was to investigate the disclosure incidence of cancer diagnosis to patients before chemotherapy, to survey the attitudes of the patients and their families and related influencing factors toward disclosure of cancer diagnosis, and to compare the anxiety and depression levels between the disclosure and non-disclosure patients. Participants and methods: A prospective cohort study was conducted at a tertiary hospital in China. A consecutive series of patients who had been diagnosed with malignancy by pathology and their family member were included in our study from March 2017 to December 2017. Patients’ situation, preferences, and their family members’ preferences were investigated by a self-designed questionnaire following a semi-structured interview. The Chinese version of HADS for anxiety and depression was used to test the patients’ psychological distress. Binary logistic regression was used to analyze the related influencing factors of patients’ disclosure of their diagnosis. Results: A total of 124 pairs of patients and their family members were analyzed. Of the 124 patients, 47 (37.90%) patients knew about their cancer diagnosis and 77 (62.10%) patients did not know about their cancer diagnosis before chemotherapy. There were more patients than family members who wanted the patients to be informed about the diagnosis of terminal illness (91.9% vs 53.2%, PPPP0.05). Conclusion: More than half of the patients did not know their exact diagnosis before chemotherapy in China. Educational level and economic status may be influencing factors for the disclosure of cancer diagnosis. Patients and their family members had different preferences toward diagnosis disclosure.
- Open Access
- 1 June 2018
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 1075-1081
The safety and accuracy of ECG-guided PICC tip position verification applied in patients with atrial fibrillation
Background: Tip position verification of peripherally inserted central catheters (PICCs) is essential to the use of the catheter. Postprocedural chest X-ray as the “gold standard” practice for PICC tip confirmation can lead to a significant delay for patient IV therapy, cost more, and lead to radiation exposure for both patients and staffs. Intracavitary electrocardiogram (IC-ECG)-guided PICC placement which provides real-time tip confirmation during the insertion procedure has been widely used. However, safety and accuracy of ECG for abnormal surface ECG patients, such as patients with atrial fibrillation (AF), have not been reported. Objective: To determine the safety and accuracy of IC-ECG technique for PICC tip position verification among the patients with AF. Patients and methods: A prospective cohort study was conducted in a teaching and tertiary referral hospital with more than 3,600 beds in Qingdao, People’s Republic of China. Adult patients with diagnosis of AF who need a PICC for infusion from June 2015 to May 2017 were enrolled in the study. For every included patient with AF, ECG was used to detect the PICC tip position during catheterization and X-ray was done to confirm the tip position as the “gold standard” after PICC insertion. The effectiveness and accuracy of ECG-guided catheter tip positioning and chest X-ray confirmation were compared. Results: Totally, 118 AF patients with 118 PICCs were enrolled (58 male and 60 female, age range 50–89 years old). There was no catheterization-related complication. When the catheter entered the lower 1/3 of superior vena cava, the amplitude of f wave reached the maximum. There was no statistical difference between X-ray PICC tip position verification and IC-ECG PICC tip position verification among patients with AF (χ2=1.31, P=0.232). Utilizing the cutoff point of f wave change ≥0.5 cm, a sensitivity of 0.94, a specificity of 0.71, a positive predictive value of 0.98, and a negative predictive value of 0.42 were observed. The area under the receiver operating characteristic curve was 0.909 (95% CI: 0.810–1.000). Conclusion: The ECG-guided technique represents a safe and accurate technique to verify the position of PICC tip in patients with AF and could potentially remove the requirement for postprocedural chest X-ray among the patients with AF.
- 1 June 2018
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 1075-1081
Open AccessThe safety and accuracy of ECG-guided PICC tip position verification applied in patients with atrial fibrillation
Background: Tip position verification of peripherally inserted central catheters (PICCs) is essential to the use of the catheter. Postprocedural chest X-ray as the “gold standard” practice for PICC tip confirmation can lead to a significant delay for patient IV therapy, cost more, and lead to radiation exposure for both patients and staffs. Intracavitary electrocardiogram (IC-ECG)-guided PICC placement which provides real-time tip confirmation during the insertion procedure has been widely used. However, safety and accuracy of ECG for abnormal surface ECG patients, such as patients with atrial fibrillation (AF), have not been reported. Objective: To determine the safety and accuracy of IC-ECG technique for PICC tip position verification among the patients with AF. Patients and methods: A prospective cohort study was conducted in a teaching and tertiary referral hospital with more than 3,600 beds in Qingdao, People’s Republic of China. Adult patients with diagnosis of AF who need a PICC for infusion from June 2015 to May 2017 were enrolled in the study. For every included patient with AF, ECG was used to detect the PICC tip position during catheterization and X-ray was done to confirm the tip position as the “gold standard” after PICC insertion. The effectiveness and accuracy of ECG-guided catheter tip positioning and chest X-ray confirmation were compared. Results: Totally, 118 AF patients with 118 PICCs were enrolled (58 male and 60 female, age range 50–89 years old). There was no catheterization-related complication. When the catheter entered the lower 1/3 of superior vena cava, the amplitude of f wave reached the maximum. There was no statistical difference between X-ray PICC tip position verification and IC-ECG PICC tip position verification among patients with AF (χ2=1.31, P=0.232). Utilizing the cutoff point of f wave change ≥0.5 cm, a sensitivity of 0.94, a specificity of 0.71, a positive predictive value of 0.98, and a negative predictive value of 0.42 were observed. The area under the receiver operating characteristic curve was 0.909 (95% CI: 0.810–1.000). Conclusion: The ECG-guided technique represents a safe and accurate technique to verify the position of PICC tip in patients with AF and could potentially remove the requirement for postprocedural chest X-ray among the patients with AF.